The NHS has adopted new scanning technology which it claims can slash diagnosis times for prostate cancer, while also reducing the risk of sepsis.
Using multi-parametric MRI (mpMRI) scanning technology – which offer a superior-quality image to current scanners – men can have a scan, receive their results and have any necessary biopsy in a day, rather than over multiple outpatient visits spanning four to six weeks via the traditional method.
The improved quality of the scans makes targeting growths on the prostate far more accurate. Currently, a biopsy may require a dozen samples having to be taken in order to locate suspect growths on the prostate.
A competition to identify a second wave of test beds will allow organisations to apply for a share of up to £6 million in funding.
NHS England and the Office for Life Sciences have launched a new competition to identify a second wave of ‘test beds’. The test bed programme is a joint programme between NHS England and government. It involves the NHS working with innovators using technology to address complex issues facing patients and the health service.
The new competition will allow businesses and NHS organisations to apply for a share of up to £6 million. This funding can be used to evaluate different combinations of innovations from small and large organisations to address a locally identified clinical challenge.
A man has had his chest rebuilt using 3D printing technology during an operation to remove a large tumour.
The prosthesis was inserted into Peter Maggs' chest after he had three ribs and half his breastbone removed.
The tumour had grown to around the size of a tennis ball, and the procedure left an extensive defect in the 71-year-old's chest.
The eight-hour operation was carried out by surgeons at Morriston Hospital, Swansea.
Surgeons would traditionally have rebuilt it with a special cement prosthesis.
Ending the fragmented way that care has been provided in the NHS using Accountable Care Organisations (ACOs).
There is widespread support for ending the fragmented way that care has been provided to improve services for patients and the NHS has been working towards this in a number of ways.
NHS England has announced it will be launching a consultation on the contracting arrangements for Accountable Care Organisations (ACOs).
ACOs are just one of these ways and are intended to allow health and care organisations to formally contract to provide services for a local population in a coordinated way. An ACO is not a new type of legal entity and so would not affect the commissioning structure of the NHS. An ACO would simply be the provider organisation which is awarded a single contract by commissioners for all the services which are within scope for the local accountable care model. Therefore any proposal to award an ACO contract would engage local commissioners’ own duties under the NHS Act 2006. Any area seeking to use an ACO contract would need to comply with longstanding public procurement law.
More than 100 entrepreneurs have been given the chance to deliver the best new technology and innovations to fully modernise the NHS.
Some 138 people have been chosen by the health service to make it fit for the 21st century, including five healthcare scientists who will tackle conditions including sickle cell disease and allergic reactions.
The Clinical Entrepreneurs Programme, run by NHS England, supports NHS workers to work with, and learn from, leading health and technology industry experts to develop their own innovative ideas. NHS England has confirmed that more staff will be provided with mentoring and other support to improve patient care.